These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6125830)

  • 1. On/off syndrome in Parkinson's disease and intravenous levodopa.
    Clough CG
    Lancet; 1982 Oct; 2(8301):765. PubMed ID: 6125830
    [No Abstract]   [Full Text] [Related]  

  • 2. On-off syndrome in Parkinson's disease and intravenous levodopa.
    Lancet; 1982 Oct; 2(8305):992-3. PubMed ID: 6127494
    [No Abstract]   [Full Text] [Related]  

  • 3. The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport.
    Nutt JG; Woodward WR; Hammerstad JP; Carter JH; Anderson JL
    N Engl J Med; 1984 Feb; 310(8):483-8. PubMed ID: 6694694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-O-methyldopa and motor fluctuations in Parkinson's disease.
    Fabbrini G; Juncos JL; Mouradian MM; Serrati C; Chase TN
    Neurology; 1987 May; 37(5):856-9. PubMed ID: 3574690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous levodopa infusions to treat complex dystonia in Parkinson's disease.
    Sage JI; McHale DM; Sonsalla P; Vitagliano D; Heikkila RE
    Neurology; 1989 Jul; 39(7):888-91. PubMed ID: 2472582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated levodopa infusions in fluctuating Parkinson's disease: clinical and pharmacokinetic data.
    Marion MH; Stocchi F; Quinn NP; Jenner P; Marsden CD
    Clin Neuropharmacol; 1986; 9(2):165-81. PubMed ID: 3708602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levodopa for Parkinson's disease.
    Devos D; Moreau C; Destée A
    N Engl J Med; 2009 Feb; 360(9):935-6; author reply 936. PubMed ID: 19246370
    [No Abstract]   [Full Text] [Related]  

  • 8. Rational management of the 'on-off' syndrome in Parkinson's disease.
    Coleman RJ
    Q J Med; 1990 Feb; 74(274):121-31. PubMed ID: 2189148
    [No Abstract]   [Full Text] [Related]  

  • 9. Conjugation of L-DOPA and its metabolites after oral and intravenous administration to Parkinsonian patients.
    Bronaugh RL; MacMurtry RJ; Hoehn MM; Rutledge CO
    Biochem Pharmacol; 1975 Jul; 24(13-14):1317-20. PubMed ID: 1096899
    [No Abstract]   [Full Text] [Related]  

  • 10. Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.
    Antonini A; Mancini F; Canesi M; Zangaglia R; Isaias IU; Manfredi L; Pacchetti C; Zibetti M; Natuzzi F; Lopiano L; Nappi G; Pezzoli G
    Neurodegener Dis; 2008; 5(3-4):244-6. PubMed ID: 18322402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa and 3-OMD levels in Parkinson patients treated with Duodopa.
    Antonini A; Bondiolotti G; Natuzzi F; Bareggi SR
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):683-7. PubMed ID: 20570113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with duodenal infusions of levodopa for the treatment of motor fluctuations in Parkinson's disease.
    Sage JI; Sonsalla PK; McHale DM; Heikkila RE; Duvoisin RC
    Adv Neurol; 1990; 53():383-6. PubMed ID: 2122646
    [No Abstract]   [Full Text] [Related]  

  • 13. Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease.
    Nyholm D
    Expert Rev Neurother; 2006 Oct; 6(10):1403-11. PubMed ID: 17078781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of intravenous and oral levodopa in patients with Parkinson's disease who exhibit on-off fluctuations.
    Hardie RJ; Malcolm SL; Lees AJ; Stern GM; Allen JG
    Br J Clin Pharmacol; 1986 Oct; 22(4):429-36. PubMed ID: 3533125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine dysregulation syndrome and punding in levodopa-carbidopa intestinal gel (LCIG) infusion: A serious but preventable complication.
    Salomone G; Marano M; di Biase L; Melgari JM; Di Lazzaro V
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1124-5. PubMed ID: 26242552
    [No Abstract]   [Full Text] [Related]  

  • 16. Continuous duodenal infusions of levodopa: plasma concentrations and motor fluctuations in Parkinson's disease.
    Sage JI; Schuh L; Heikkila RE; Duvoisin RC
    Clin Neuropharmacol; 1988 Feb; 11(1):36-44. PubMed ID: 3349496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa in the treatment of Parkinson's disease.
    Lloyd KG
    Prim Care; 1977 Sep; 4(3):541-60. PubMed ID: 264229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum vitamin B(12) and folate levels in Parkinson's disease patients treated with duodenal levodopa infusion.
    Santos-García D; Macías M; Llaneza M; Grande M; de la Fuente-Fernández R
    Mov Disord; 2011 Feb; 26(3):558-9. PubMed ID: 20960480
    [No Abstract]   [Full Text] [Related]  

  • 19. [Duodenale levodopa and apomorphine infusion for motor complications in advanced Parkinson's disease].
    Antonini A; Jost WH
    Fortschr Neurol Psychiatr; 2018 Sep; 86(S 01):S5-S9. PubMed ID: 30107620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New levodopa therapeutic strategies.
    LeWitt PA
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S37-40. PubMed ID: 26459662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.